Cystic fibrosis: comorbidity with other serious diseases

Numerous epidemiological studies demonstrate that cystic fibrosis, the most common orphan disease in the world, can not occur in isolation, but can be combined with other serious diseases. The most common such combination in all populations is traditionally cystic fibrosis and celiac disease, which, on the one hand, differ in the leading mechanism of inflammation, in cystic fibrosis - chronic microbial inflammation, in celiac disease - autoimmune, on the other hand, these two diseases have a number of common pathogenesis links, in particular, realizing the syndrome of malabsorption, which only complicates the timely diagnosis of these combined pathological conditions. In addition, the authors of the literature review focus on clinical examples of late detection of autoimmune gluten intolerance against the background of cystic fibrosis. They also consider the combination of cystic fibrosis with other severe, disabling diseases (rheumatoid arthritis, phenylketonuria, oncological diseases), which sometimes require a serious change in therapeutic tactics.

[1]  H. Gavillet,et al.  Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis , 2022, Microbiology spectrum.

[2]  L. Decosterd,et al.  Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now? , 2022, Pharmaceutics.

[3]  T. Sferra,et al.  Epidemiology of Eosinophilic Esophagitis in Patients with Cystic Fibrosis: A Population-Based 5-Year Study , 2022, Pediatric gastroenterology, hepatology & nutrition.

[4]  D. Sanders,et al.  Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus , 2022, Gut.

[5]  A. Gala-Błądzińska,et al.  Renal Function in Patients with Cystic Fibrosis: A Single-Center Study , 2022, International journal of environmental research and public health.

[6]  S. Almeida,et al.  Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study , 2022, BMJ Paediatrics Open.

[7]  I. Esposito,et al.  CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis , 2022, Cells.

[8]  G. Deslée,et al.  Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients , 2022, Frontiers in Medicine.

[9]  C. Y. Ooi,et al.  What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics? , 2022, Nutrients.

[10]  H. Ellemunter,et al.  Malignancies in patients with cystic fibrosis: a case series , 2022, Journal of Medical Case Reports.

[11]  P. Maisonneuve,et al.  Cancer in Cystic Fibrosis: A Narrative Review of Prevalence, Risk Factors, Screening and Treatment Challenges. , 2021, Chest.

[12]  P. Hegyi,et al.  Increased Prevalence of Celiac Disease in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis , 2021, Journal of personalized medicine.

[13]  P. Cullinan,et al.  Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study. , 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[14]  L. Marciani,et al.  Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls , 2021, medRxiv.

[15]  D. Goldfarb,et al.  Urinary stone disease prevalence and associations in cystic fibrosis , 2021, Urolithiasis.

[16]  M. Zali,et al.  Prevalence of celiac disease in low and high risk population in Asia–Pacific region: a systematic review and meta-analysis , 2021, Scientific Reports.

[17]  Jianfeng Xu,et al.  Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank , 2020, International journal of cancer.

[18]  C. Siva,et al.  Rheumatoid arthritis in a patient with cystic fibrosis: challenging treatment options , 2020, BMJ Case Reports.

[19]  M. Zali,et al.  An updated overview of spectrum of gluten-related disorders: clinical and diagnostic aspects , 2020, BMC Gastroenterology.

[20]  P. Palange,et al.  Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis , 2019, Journal of Translational Medicine.

[21]  H. Green,et al.  24. Chronic inflammatory arthritis in the context of cystic fibrosis , 2019, Rheumatology Advances in Practice.

[22]  G. Kroemer,et al.  Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease , 2019, Oncotarget.

[23]  C. Lightdale,et al.  Cystic fibrosis is associated with an increased risk of Barrett's esophagus. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[24]  M. Nikolski,et al.  Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn’s-Like Microbiota Disturbances , 2019, Journal of clinical medicine.

[25]  D. Sanders,et al.  European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders , 2019, United European gastroenterology journal.

[26]  G. Kroemer,et al.  Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease , 2019, Aging.

[27]  M. Walshaw,et al.  Evaluation of Gastric Emptying in Cystic Fibrosis Using Bedside Ultrasonography , 2019, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[28]  G. Kroemer,et al.  The gliadin-CFTR connection: new perspectives for the treatment of celiac disease , 2019, Italian Journal of Pediatrics.

[29]  M. Ramírez,et al.  Crohns disease and cystic fibrosis: there is still a lot to learn , 2018 .

[30]  P. H. Green,et al.  Global Prevalence of Celiac Disease: Systematic Review and Meta‐analysis , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  A. Zauber,et al.  Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations. , 2017, Gastroenterology.

[32]  L. Ryom,et al.  Prevalence and characteristics of chronic kidney disease among Danish adults with cystic fibrosis. , 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[33]  M. Putman,et al.  Celiac Disease in Patients with Cystic Fibrosis-Related Bone Disease , 2017, Case reports in endocrinology.

[34]  Vikesh K. Singh,et al.  Pancreatic insufficiency in Cystic Fibrosis. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[35]  M. Haupt,et al.  The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin , 2017, Journal of gastroenterology.

[36]  C. Y. Ooi,et al.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy , 2017, Current Gastroenterology Reports.

[37]  S. Gangloff,et al.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies , 2016, Osteoporosis International.

[38]  J. Bai,et al.  Bone and Celiac Disease , 2016, Current Osteoporosis Reports.

[39]  C. Gallagher,et al.  Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: a case report. , 2014, Journal of Crohn's & colitis.

[40]  Emily A. Knapp,et al.  Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. , 2013, Journal of the National Cancer Institute.

[41]  R. Medzhitov,et al.  Abnormal Trafficking and Degradation of TLR4 Underlie the Elevated Inflammatory Response in Cystic Fibrosis , 2011, The Journal of Immunology.

[42]  Nikolina Zdraveska,et al.  Coagulopathy as initial manifestation of concomitant celiac disease and cystic fibrosis: a case report , 2011, Journal of medical case reports.

[43]  J. Walkowiak,et al.  Cystic fibrosis is a risk factor for celiac disease. , 2010, Acta biochimica Polonica.

[44]  G. Lenoir,et al.  In Cystic Fibrosis Homozygotes and Heterozygotes, Neutrophil Apoptosis Is Delayed and Modulated by Diamide or Roscovitine: Evidence for an Innate Neutrophil Disturbance , 2010, Journal of Innate Immunity.

[45]  T. Pressler,et al.  Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[46]  P. Miossec IL-17 and Th17 cells in human inflammatory diseases. , 2009, Microbes and infection.

[47]  E. Chilvers,et al.  Prolonged survival of neutrophils from patients with ΔF508 CFTR mutations , 2008, Thorax.

[48]  E. Aktas,et al.  Prevalence of Celiac Disease in Turkish Children , 2005, Journal of clinical gastroenterology.

[49]  J. Kolls,et al.  Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis 1 , 2005, The Journal of Immunology.

[50]  V. Raia,et al.  Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration , 2004, Alimentary pharmacology & therapeutics.

[51]  D. Hume,et al.  G551D Cystic Fibrosis Mice Exhibit Abnormal Regulation of Inflammation in Lungs and Macrophages1 , 2000, The Journal of Immunology.

[52]  K. Bendtzen,et al.  Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. , 1993, Pediatric pulmonology.

[53]  S. Freedman,et al.  Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophages. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.